58 results on '"D'Agostino DM"'
Search Results
2. Impact of the HTLV-1 p13II protein on cell growth and tumorigenesis
- Author
-
Ciminale, V., Silic-Benussi, M., D Agostino, Dm, Cavallari, I., Zorzan, T., Antonio Rosato, Willems, L., Lairmore, Md, Chieco-Bianchi, L., and Rossi, E.
- Published
- 2003
3. Functional analysis of the p13II protein of HTLV-1
- Author
-
Ciminale, V., Ranzato, L., Ferro, T., Cavallari, I., Silic-Benussi, M., Marin, O., Valeria Petronilli, Bernardi, P., D Agostino, Dm, and Chieco-Bianchi, L.
4. Differential expression of menin in sporadic pituitary adenomas
- Author
-
Uberto Pagotto, Ludwig Schaaf, Thomas Arzberger, Vincenzo Ciminale, Yvonne Grübler, Marco Losa, Francesco Fallo, Tiziana Ferro, Marily Theodoropoulou, Luisa Barzon, Ilaria Cavallari, Gk Stalla, Dm D'Agostino, Theodoropoulou, M., Cavallari, I., Barzon, L., D'Agostino, D. M., Ferro, T., Arzberger, T., Grübler, Y., Schaaf, L., Losa, M., Fallo, F., Ciminale, V., Stalla, G. K., Pagotto, U., THEODOROPOULOU M, CAVALLARI I, BARZON L, D'AGOSTINO DM, FERRO T, ARZBERGER T, GRUBLER Y, SCHAAF L, LOSA M, FALLO F, CIMINALE V, STALLA GK, and PAGOTTO U.
- Subjects
Adenoma ,Adult ,Male ,congenital, hereditary, and neonatal diseases and abnormalities ,endocrine system ,Pathology ,medicine.medical_specialty ,Pituitary gland ,Cancer Research ,Adolescent ,endocrine system diseases ,Endocrinology, Diabetes and Metabolism ,Pituitary neoplasm ,Biology ,Immunoenzyme Techniques ,Endocrinology ,Proto-Oncogene Proteins ,medicine ,Humans ,Genes, Tumor Suppressor ,Neoplasm Invasiveness ,Pituitary Neoplasms ,MEN1 ,Nuclear protein ,Multiple endocrine neoplasia ,Aged ,Aged, 80 and over ,Middle Aged ,medicine.disease ,medicine.anatomical_structure ,Oncology ,Pituitary Gland ,Pituitary carcinoma ,Immunohistochemistry ,Female - Abstract
Pituitary adenomas represent one of the key features of multiple endocrine neoplasia type 1. The gene involved in this syndrome (MEN1) is a putative tumor suppressor, that codes for a 610-amino acid nuclear protein termed 'menin'. Analyses of sporadic pituitary adenomas have so far failed to reveal MEN1 mutations or defects in MEN1 transcription in these tumors. In the present study we detected menin protein expression in a panel of normal and tumoral pituitary tissues, using a monoclonal antibody against the carboxy-terminus of menin. In the normal human pituitary gland, strong nuclear staining for menin was detectable in the majority of the endocrine cells of the anterior lobe, without a clear association with a particular hormone-producing type. In sporadic pituitary adenomas, menin expression was variable, with a high percentage of cases demonstrating a significant decrease in menin immunoreactivity when compared with the normal pituitary. Interestingly, metastatic tissues derived from one pituitary carcinoma had no detectable menin levels. Altogether, our data provide the first information regarding the status of menin expression in human normal and neoplastic pituitary as determined by immunohistochemistry (IHC).
- Published
- 2004
5. Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus.
- Author
-
Silic-Benussi M, Sharova E, Corradin A, Urso L, Raimondi V, Cavallari I, Buldini B, Francescato S, Minuzzo SA, D'Agostino DM, and Ciminale V
- Abstract
New therapies are needed for patients with T-cell lymphoblastic leukemia (T-ALL) who do not respond to standard chemotherapy. Our previous studies showed that the mTORC1 inhibitor everolimus increases reactive oxygen species (ROS) levels, decreases the levels of NADPH and glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme of the pentose phosphate pathway (PPP), and induces apoptosis in T-ALL cells. Studies in T-ALL-xenografted NOD/SCID mice demonstrated that everolimus improved their response to the glucocorticoid (GC) dexamethasone. Here we show that verapamil, a calcium antagonist used in the treatment of supraventricular tachyarrhythmias, enhanced the effects of everolimus on ROS and cell death in T-ALL cell lines. The death-enhancing effect was synergistic and was confirmed in assays on a panel of therapy-resistant patient-derived xenografts (PDX) and primary samples from T-ALL patients. The verapamil-everolimus combination produced a dramatic reduction in the levels of G6PD and induction of p38 MAPK phosphorylation. Studies of NOD/SCID mice inoculated with refractory T-ALL PDX cells demonstrated that the addition of verapamil to everolimus plus dexamethasone significantly reduced tumor growth in vivo. Taken together, our results provide a rationale for repurposing verapamil in association with mTORC inhibitors and GC to treat refractory T-ALL.
- Published
- 2023
- Full Text
- View/download PDF
6. MiR-150 in HTLV-1 infection and T-cell transformation.
- Author
-
D'Agostino DM, Raimondi V, Silic-Benussi M, and Ciminale V
- Subjects
- Human T-lymphotropic virus 1, Humans, CD4-Positive T-Lymphocytes cytology, CD4-Positive T-Lymphocytes virology, Leukemia-Lymphoma, Adult T-Cell genetics, MicroRNAs genetics, Paraparesis, Tropical Spastic genetics
- Abstract
Human T-cell leukemia virus-1 (HTLV-1) is a retrovirus that persistently infects CD4+ T-cells, and is the causative agent of adult T-cell leukemia/lymphoma (ATLL), tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM) and several inflammatory diseases. T-cell transformation by HTLV-1 is driven by multiple interactions between viral regulatory proteins and host cell pathways that govern cell proliferation and survival. Studies performed over the last decade have revealed alterations in the expression of many microRNAs in HTLV-1-infected cells and ATLL cells, and have identified several microRNA targets with roles in the viral life cycle and host cell turnover. This review centers on miR-150-5p, a microRNA whose expression is temporally regulated during lymphocyte development and altered in several hematological malignancies. The levels of miR-150-5p are reduced in many HTLV-1-transformed- and ATLL-derived cell lines. Experiments in these cell lines showed that downregulation of miR-150-5p results in activation of the transcription factor STAT1, which is a direct target of the miRNA. However, data on miR-150-5p levels in freshly isolated ATLL samples are suggestive of its upregulation compared to controls. These apparently puzzling findings highlight the need for more in-depth studies of the role of miR-150-5p in HTLV-1 infection and pathogenesis based on knowledge of miR-150-5p-target mRNA interactions and mechanisms regulating its function in normal leukocytes and hematologic neoplasms., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 D’Agostino, Raimondi, Silic-Benussi and Ciminale.)
- Published
- 2022
- Full Text
- View/download PDF
7. mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells.
- Author
-
Silic-Benussi M, Sharova E, Ciccarese F, Cavallari I, Raimondi V, Urso L, Corradin A, Kotler H, Scattolin G, Buldini B, Francescato S, Basso G, Minuzzo SA, Indraccolo S, D'Agostino DM, and Ciminale V
- Subjects
- Animals, Apoptosis, Cell Line, Tumor, Dexamethasone pharmacology, Dexamethasone therapeutic use, Everolimus pharmacology, Everolimus therapeutic use, Glucosephosphate Dehydrogenase genetics, Glucosephosphate Dehydrogenase metabolism, Humans, MTOR Inhibitors, Mice, Mice, Inbred NOD, Mice, SCID, NADP, Reactive Oxygen Species metabolism, T-Lymphocytes metabolism, TOR Serine-Threonine Kinases metabolism, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma drug therapy, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma genetics, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma metabolism
- Abstract
mTOR activation is a hallmark of T-cell acute lymphoblastic leukemia (T-ALL) and is associated with resistance to glucocorticoid (GC)-based chemotherapy. We previously showed that altering redox homeostasis primes T-ALL cells to GC-induced apoptosis. Here we investigated the connection between the mTOR pathway and redox homeostasis using pharmacological inhibitors and gene silencing. In vitro studies performed on T-ALL cell lines and CG-resistant patient-derived T-ALL xenograft (PDX) cells showed that the mTOR inhibitor everolimus increased reactive oxygen species (ROS) levels, augmented lipid peroxidation, and activated the ROS-controlled transcription factor NRF2. These effects were accompanied by a decrease in the levels of NADPH and of glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme of the pentose phosphate pathway (PPP), which is a major source of cytosolic NADPH needed for maintaining the cellular ROS-scavenging capacity. The mTOR inhibitor everolimus induced mitochondrial inner membrane depolarization and dose-dependent apoptosis of T-ALL cells, but did not kill normal T-cells. Importantly, the combination of everolimus and the GC dexamethasone had a synergistic effect on killing T-ALL cells. The effects of mTOR inhibition were blunted by ROS scavengers and phenocopied by siRNA-mediated G6PD silencing. In vivo studies of NOD/SCID mice inoculated with refractory T-ALL PDX demonstrated that everolimus overcame dexamethasone resistance in conditions of high tumor burden that mimicked the clinical setting of acute leukemia. These findings provide insight into the crosstalk between mTOR and ROS homeostasis in T-ALL cells and furnish mechanistic evidence to support the combination of glucocorticoids with mTOR inhibitors as a therapeutic avenue for treating refractory T-ALL., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
8. The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.
- Author
-
Cavallari I, Ciccarese F, Sharova E, Urso L, Raimondi V, Silic-Benussi M, D'Agostino DM, and Ciminale V
- Abstract
The miR-200 family of microRNAs (miRNAs) includes miR-200a, miR-200b, miR-200c, miR-141 and miR-429, five evolutionarily conserved miRNAs that are encoded in two clusters of hairpin precursors located on human chromosome 1 (miR-200b, miR-200a and miR-429) and chromosome 12 (miR-200c and miR-141). The mature -3p products of the precursors are abundantly expressed in epithelial cells, where they contribute to maintaining the epithelial phenotype by repressing expression of factors that favor the process of epithelial-to-mesenchymal transition (EMT), a key hallmark of oncogenic transformation. Extensive studies of the expression and interactions of these miRNAs with cell signaling pathways indicate that they can exert both tumor suppressor- and pro-metastatic functions, and may serve as biomarkers of epithelial cancers. This review provides a summary of the role of miR-200 family members in EMT, factors that regulate their expression, and important targets for miR-200-mediated repression that are involved in EMT. The second part of the review discusses the potential utility of circulating miR-200 family members as diagnostic/prognostic biomarkers for breast, colorectal, lung, ovarian, prostate and bladder cancers.
- Published
- 2021
- Full Text
- View/download PDF
9. Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer.
- Author
-
Todeschini P, Salviato E, Romani C, Raimondi V, Ciccarese F, Ferrari F, Tognon G, Marchini S, D'Incalci M, Zanotti L, Ravaggi A, Odicino F, Sartori E, D'Agostino DM, Samaja M, Romualdi C, and Bignotti E
- Abstract
The onset of chemo-resistant recurrence represents the principal cause of high-grade serous ovarian carcinoma (HGSOC) death. HGSOC masses are characterized by a hypoxic microenvironment, which contributes to the development of this chemo-resistant phenotype. Hypoxia regulated-miRNAs (HRMs) represent a molecular response of cancer cells to hypoxia and are involved in tumor progression. We investigated the expression of HRMs using miRNA expression data from a total of 273 advanced-stage HGSOC samples. The miRNAs associated with chemoresistance and survival were validated by RT-qPCR and target prediction, and comparative pathway analysis was conducted for target gene identification. Analysis of miRNA expression profiles indicated miR-23a-3p and miR-181c-5p over-expression as associated with chemoresistance and poor PFS. RT-qPCR data confirmed upregulation of miR-23a-3p in tumors from chemoresistant HGSOC patients and its significant association with shorter PFS. In silico miR-23a-3p target prediction and comparative pathway analysis identified platinum drug resistance as the pathway with the highest number of miR-23a-3p target genes. Among them, APAF-1 emerged as the most promising, being downregulated in platinum-resistant patients and in HGSOC chemo-resistant cells. These results highlight miR-23a-3p as a potential biomarker for HGSOC platinum response and prognosis and the miR23a-3p/APAF1 axis as a possible target to overcome platinum-resistance.
- Published
- 2021
- Full Text
- View/download PDF
10. Prognostic Stratification of Bladder Cancer Patients with a MicroRNA-based Approach.
- Author
-
Cavallari I, Grassi A, Del Bianco P, Aceti A, Zaborra C, Sharova E, Bertazzolo I, D'Agostino DM, Iafrate M, and Ciminale V
- Abstract
Robust non-invasive tests for prognostic stratification of bladder cancer (BCa) patients are in high demand. Following a comprehensive analysis of studies on BCa, we selected a panel of 29 microRNAs (miRNAs) and analyzed their levels in urine and plasma samples in a prospective cohort of 63 BCa patients (32 at high risk of recurrence and 31 low-risk cases) and 37 healthy controls using RT-qPCR. To design an assay suitable for large-scale testing, we applied a hierarchical pipeline to select the miRNAs that were not affected by confounding factors such as haematuria and urine specific gravity, and exceeded stringent cut-off criteria (fold change >2.5 and p- value < 0.005). Using a two-step decision tree based on the urine levels of miR-34a-5p, miR-200a-3p and miR-193a-5p, normalized against miR-125b-5p, patients could be classified as high- or low-risk with a sensitivity of 0.844, specificity of 0.806 and accuracy of 0.825. Furthermore, univariate Cox proportional hazards regression analyses indicated that increased urine levels of miR-29a-3p, miR-34a-5p, miR-193a-5p, miR-200c-3p, miR-205-5p and miR-532-5p were associated with a shorter event-free survival (hazard ratios > 3.1, p - value < 0.05). Taken together, our findings suggest that measuring the urine levels of these miRNAs could provide a novel cost-effective, noninvasive test for risk assessment of BCa patients.
- Published
- 2020
- Full Text
- View/download PDF
11. Functional properties and sequence variation of HTLV-1 p13.
- Author
-
Omsland M, Silic-Benussi M, Moles R, Sarkis S, Purcell DFJ, Yurick D, Khoury G, D'Agostino DM, Ciminale V, and Franchini G
- Subjects
- Animals, Humans, Open Reading Frames, Genetic Variation, Human T-lymphotropic virus 1 genetics, Retroviridae Proteins genetics
- Abstract
Human T cell leukemia virus type-1 (HTLV-1) was the first retrovirus found to cause cancer in humans, but the mechanisms that drive the development of leukemia and other diseases associated with HTLV-1 infection remain to be fully understood. This review describes the functional properties of p13, an 87-amino acid protein coded by HTLV-1 open reading frame II (orf-II). p13 is mainly localized in the inner membrane of the mitochondria, where it induces potassium (K
+ ) influx and reactive oxygen species (ROS) production, which can trigger either proliferation or apoptosis, depending on the ROS setpoint of the cell. Recent evidence indicates that p13 may influence the cell's innate immune response to viral infection and the infected cell phenotype. Association of the HTLV-1 transcriptional activator, Tax, with p13 increases p13's stability, leads to its partial co-localization with Tax in nuclear speckles, and reduces the ability of Tax to interact with the transcription cofactor CBP/p300. Comparison of p13 sequences isolated from HTLV-1-infected individuals revealed a small number of amino acid variations in the domains controlling the subcellular localization of the protein. Disruptive mutations of p13 were found in samples obtained from asymptomatic patients with low proviral load. p13 sequences of HTLV-1 subtype C isolates from indigenous Australian patients showed a high degree of identity among each other, with all samples containing a pattern of 5 amino acids that distinguished them from other subtypes. Further characterization of p13's functional properties and sequence variants may lead to a deeper understanding of the impact of p13 as a contributor to the clinical manifestations of HTLV-1 infection.- Published
- 2020
- Full Text
- View/download PDF
12. NF-κB and MicroRNA Deregulation Mediated by HTLV-1 Tax and HBZ.
- Author
-
Fochi S, Ciminale V, Trabetti E, Bertazzoni U, D'Agostino DM, Zipeto D, and Romanelli MG
- Abstract
The risk of developing adult T-cell leukemia/lymphoma (ATLL) in individuals infected with human T-cell lymphotropic virus 1 (HTLV-1) is about 3-5%. The mechanisms by which the virus triggers this aggressive cancer are still an area of intensive investigation. The viral protein Tax-1, together with additional regulatory proteins, in particular HTLV-1 basic leucine zipper factor (HBZ), are recognized as relevant viral factors required for both viral replication and transformation of infected cells. Tax-1 deregulates several cellular pathways affecting the cell cycle, survival, and proliferation. The effects of Tax-1 on the NF-κB pathway have been thoroughly studied. Recent studies also revealed the impact of Tax-1 and HBZ on microRNA expression. In this review, we summarize the recent progress in understanding the contribution of HTLV-1 Tax- and HBZ-mediated deregulation of NF-κB and the microRNA regulatory network to HTLV-1 pathogenesis.
- Published
- 2019
- Full Text
- View/download PDF
13. Post-transcriptional Regulation of HTLV Gene Expression: Rex to the Rescue.
- Author
-
D'Agostino DM, Cavallari I, Romanelli MG, and Ciminale V
- Abstract
Human T-lymphotropic virus type 1 (HTLV-1) and other members of the Deltaretrovirus genus code for a regulatory protein named Rex that binds to the Rex-responsive element present on viral mRNAs. Rex rescues viral mRNAs from complete splicing or degradation and guides them to the cytoplasm for translation. The activity of Rex is essential for expression of viral transcripts coding for the virion components and thus represents a potential target for virus eradication. We present an overview of the functional properties of the HTLV-1 and HTLV-2 Rex proteins (Rex-1 and Rex-2), outline mechanisms controlling Rex function, and discuss similarities and differences in the sequences of Rex coded by HTLV-1, -2, -3, and -4 that may influence their molecular anatomy and functional properties.
- Published
- 2019
- Full Text
- View/download PDF
14. Selective killing of human T-ALL cells: an integrated approach targeting redox homeostasis and the OMA1/OPA1 axis.
- Author
-
Silic-Benussi M, Scattolin G, Cavallari I, Minuzzo S, Del Bianco P, Francescato S, Basso G, Indraccolo S, D'Agostino DM, and Ciminale V
- Subjects
- Animals, Apoptosis drug effects, Benzimidazoles chemistry, Benzimidazoles pharmacology, Benzimidazoles therapeutic use, Dehydroepiandrosterone pharmacology, Dehydroepiandrosterone therapeutic use, Humans, Mice, Mice, Inbred NOD, Mice, SCID, Mitochondria metabolism, Mitochondria pathology, Mitochondrial Proteins metabolism, NF-E2-Related Factor 2 metabolism, Oxidation-Reduction, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma drug therapy, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma metabolism, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma pathology, Reactive Oxygen Species chemistry, Reactive Oxygen Species metabolism, T-Lymphocytes cytology, T-Lymphocytes drug effects, T-Lymphocytes metabolism, TNF-Related Apoptosis-Inducing Ligand pharmacology, Transplantation, Heterologous, GTP Phosphohydrolases metabolism, Metalloendopeptidases metabolism
- Abstract
Approximately 20% of pediatric T-cell acute lymphoblastic leukemia (T-ALL) patients are currently incurable due to primary or secondary resistance to glucocorticoid-based therapies. Here we employed an integrated approach to selectively kill T-ALL cells by increasing mitochondrial reactive oxygen species (ROS) using NS1619, a benzimidazolone that activates the K
+ (BK) channel, and dehydroepiandrosterone (DHEA), which blunts ROS scavenging through inhibition of the pentose phosphate pathway. These compounds selectively killed T-ALL cell lines, patient-derived xenografts and primary cells from patients with refractory T-ALL, but did not kill normal human thymocytes. T-ALL cells treated with NS1619 and DHEA showed activation of the ROS-responsive transcription factor NRF2, indicating engagement of antioxidant pathways, as well as increased cleavage of OPA1, a mitochondrial protein that promotes mitochondrial fusion and regulates apoptosis. Consistent with these observations, transmission electron microscopy analysis indicated that NS1619 and DHEA increased mitochondrial fission. OPA1 cleavage and cell death were inhibited by ROS scavengers and by siRNA-mediated knockdown of the mitochondrial protease OMA1, indicating the engagement of a ROS-OMA1-OPA1 axis in T-ALL cells. Furthermore, NS1619 and DHEA sensitized T-ALL cells to TRAIL-induced apoptosis. In vivo, the combination of dexamethasone and NS1619 significantly reduced the growth of a glucocorticoid-resistant patient-derived T-ALL xenograft. Taken together, our findings provide proof-of-principle for an integrated ROS-based pharmacological approach to target refractory T-ALL.- Published
- 2018
- Full Text
- View/download PDF
15. Expression of miR-34a in T-Cells Infected by Human T-Lymphotropic Virus 1.
- Author
-
Sharma VK, Raimondi V, Ruggero K, Pise-Masison CA, Cavallari I, Silic-Benussi M, Ciminale V, and D'Agostino DM
- Abstract
Human T-lymphotropic virus 1 (HTLV-1) immortalizes T-cells and is the causative agent of adult T-cell leukemia/lymphoma (ATLL). HTLV-1 replication and transformation are governed by multiple interactions between viral regulatory proteins and host cell factors that remain to be fully elucidated. The present study investigated the impact of HTLV-1 infection on the expression of miR-34a, a microRNA whose expression is downregulated in many types of cancer. Results of RT-PCR assays showed that five out of six HTLV-1-positive cell lines expressed higher levels of miR-34a compared to normal PBMC or purified CD4+ T-cells. ATLL cell line ED, which did not express miR-34a, showed methylation of the miR-34a promoter. Newly infected PBMC and samples from 10 ATLL patients also showed a prominent increase in miR-34a expression compared to PBMC controls. The primary miR-34a transcript expressed in infected cell line C91PL contained binding motifs for NF-κB and p53. Pharmacological inhibition of NF-κB with Bay 11-7082 indicated that this pathway contributes to sustain miR-34a levels in infected cells. Treatment of infected cell lines with the p53 activator nutlin-3a resulted in a further increase in miR-34a levels, thus confirming it as a transcriptional target of p53. Nutlin-3a-treated cells showed downregulation of known miR-34a targets including the deacetylase SIRT1, which was accompanied by increased acetylation of p53, a substrate of SIRT1. Transfection of C91PL cells with a miR-34a mimic also led to downregulation of mRNA targets including SIRT1 as well as the pro-apoptotic factor BAX. Unlike nutlin-3a, the miR-34a mimic did not cause cell cycle arrest or reduce cell viability. On the other hand, sequestration of miR-34a with a sponge construct resulted in an increase in death of C91PL cells. These findings provide evidence for a functional role for miR-34a in fine-tuning the expression of target genes that influence the turnover of HTLV-1-infected cells.
- Published
- 2018
- Full Text
- View/download PDF
16. Mitochondrial Proteins Coded by Human Tumor Viruses.
- Author
-
Cavallari I, Scattolin G, Silic-Benussi M, Raimondi V, D'Agostino DM, and Ciminale V
- Abstract
Viruses must exploit the cellular biosynthetic machinery and evade cellular defense systems to complete their life cycles. Due to their crucial roles in cellular bioenergetics, apoptosis, innate immunity and redox balance, mitochondria are important functional targets of many viruses, including tumor viruses. The present review describes the interactions between mitochondria and proteins coded by the human tumor viruses human T-cell leukemia virus type 1, Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, human hepatitis viruses B and C, and human papillomavirus, and highlights how these interactions contribute to viral replication, persistence and transformation.
- Published
- 2018
- Full Text
- View/download PDF
17. STR Profiling of HTLV-1-Infected Cell Lines.
- Author
-
Raimondi V, Minuzzo S, Ciminale V, and D'Agostino DM
- Subjects
- Humans, Jurkat Cells, DNA, Viral genetics, HTLV-I Infections genetics, Human T-lymphotropic virus 1 genetics, Microsatellite Repeats
- Abstract
Many investigations of the replication and pathogenesis of human T-cell leukemia virus type 1 (HTLV-1) employ chronically infected cell lines, cell lines stabilized from primary adult T-cell leukemia cells, and noninfected T-cell lines. The validity of data obtained from such studies depends on the unambiguous identification of each cell line, which can be performed by short-tandem-repeat (STR) profiling (DNA fingerprinting). While kit-based profiling represents the standard method for cell line authentication, not all labs have ready access to the required capillary electrophoresis equipment, and the costs of such tests can become substantial, especially if the cell lines are to be tested frequently. We analyzed DNA from a panel of HTLV-1-infected cell lines and noninfected T-cell lines using a commercial STR kit and then analyzed the same DNA for individual STR markers followed by nondenaturing polyacrylamide gel electrophoresis. This simplified method should facilitate routine confirmation of cell line identity in diverse laboratory settings.
- Published
- 2017
- Full Text
- View/download PDF
18. A circulating miRNA assay as a first-line test for prostate cancer screening.
- Author
-
Sharova E, Grassi A, Marcer A, Ruggero K, Pinto F, Bassi P, Zanovello P, Zattoni F, D'Agostino DM, Iafrate M, and Ciminale V
- Subjects
- Aged, Biomarkers, Tumor blood, Biomarkers, Tumor genetics, Early Detection of Cancer methods, Humans, Male, Prostatic Hyperplasia diagnosis, Prostatic Neoplasms pathology, MicroRNAs blood, Prostatic Hyperplasia blood, Prostatic Hyperplasia genetics, Prostatic Neoplasms blood, Prostatic Neoplasms genetics
- Abstract
Background: Prostate cancer (PCa) screening currently relies on prostate-specific antigen (PSA) testing and digital rectal examination. However, recent large-scale studies have questioned the long-term efficacy of these tests, and biomarkers that accurately identify PCa are needed., Methods: We analysed the levels of circulating microRNAs (miRNAs) in patients with elevated PSA who were diagnosed with either localised PCa (n=36) or benign prostatic hyperplasia (BPH, n=31) upon biopsy. Real-time RT-PCR with Taqman probes was used to measure plasma levels of miRNAs. To circumvent problems associated with circulating miRNA quantitation, we computed the expression ratios of upregulated and downregulated miRNAs., Results: The miR-106a/miR-130b and miR-106a/miR-223 ratios were significantly different between the biopsy-positive and BPH groups (P<0.0001), and yielded statistical power values that were >0.99. Both miRNA ratios were highly sensitive and more specific than PSA in discriminating localised PCa from BPH. Receiver operating characteristic curve analysis revealed area under curve values of 0.81 (miR-106a/miR-130b) and 0.77 (miR-106a/miR-223)., Conclusions: Testing for circulating miR-106a/miR-130b and miR-106a/miR-223 ratios may reduce the costs and morbidity of unnecessary biopsies and is feasible for large-scale screening, as it requires measuring only three miRNAs.
- Published
- 2016
- Full Text
- View/download PDF
19. Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).
- Author
-
Bassuk SS, Manson JE, Lee IM, Cook NR, Christen WG, Bubes VY, Gordon DS, Copeland T, Friedenberg G, D'Agostino DM, Ridge CY, MacFadyen JG, Kalan K, and Buring JE
- Subjects
- Aged, Aged, 80 and over, Clinical Protocols, Double-Blind Method, Drug Combinations, Female, Humans, Male, Middle Aged, Patient Selection, Research Design, Cardiovascular Diseases prevention & control, Cholecalciferol therapeutic use, Dietary Supplements, Docosahexaenoic Acids therapeutic use, Eicosapentaenoic Acid therapeutic use, Neoplasms prevention & control, Primary Prevention methods, Vitamins therapeutic use
- Abstract
Evidence for a role of supplemental vitamin D and marine omega-3 fatty acids in preventing cancer and cardiovascular disease (CVD) remains inconclusive and insufficient to inform nutritional recommendations for primary prevention. The VITamin D and Omega-A 3 TriaL (VITAL) is an ongoing nationwide, randomized, double-blind, placebo-controlled clinical trial designed to fill this knowledge gap. The study population consists of 25,874 U.S. adults without cancer or CVD at baseline, who were selected only on age (men aged ≥50 and women aged ≥55), with an oversampling of African Americans (n=5,107). In a 2 × 2 factorial design, participants were randomized to one of four supplement groups: [1] active vitamin D3 (cholecalciferol; 2000 IU/d) and active marine omega-3 fatty acids (Omacor® fish oil, eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA], 1g/d); [2] active vitamin D and omega-3 placebo; [3] vitamin D placebo and active marine omega-3 fatty acids; or [4] vitamin D placebo and omega-3 placebo. The mean length of the randomized treatment period will be 5 years. The randomization was successful, as evidenced by similar distributions of baseline demographic, health, and behavioral characteristics across treatment groups. The similar distribution of known potential confounders across treatment groups strongly suggests that unmeasured or unknown potential confounders are also equally distributed. VITAL is expected to provide important information on the benefit-risk balance of vitamin D and omega-3 fatty acid supplementation when taken for the primary prevention of cancer and CVD., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
20. Expression of Alternatively Spliced Human T-Cell Leukemia Virus Type 1 mRNAs Is Influenced by Mitosis and by a Novel cis-Acting Regulatory Sequence.
- Author
-
Cavallari I, Rende F, Bona MK, Sztuba-Solinska J, Silic-Benussi M, Tognon M, LeGrice SF, Franchini G, D'Agostino DM, and Ciminale V
- Subjects
- Gene Expression, Gene Expression Profiling, Gene Knockout Techniques, Gene Products, rex deficiency, Gene Products, rex genetics, HeLa Cells, Humans, RNA, Messenger genetics, RNA, Viral genetics, Regulatory Sequences, Ribonucleic Acid, Gene Expression Regulation, Viral, Host-Pathogen Interactions, Human T-lymphotropic virus 1 genetics, Mitosis, RNA Splicing, RNA, Messenger metabolism, RNA, Viral metabolism
- Abstract
Unlabelled: Human T-cell leukemia virus type 1 (HTLV-1) expression depends on the concerted action of Tax, which drives transcription of the viral genome, and Rex, which favors expression of incompletely spliced mRNAs and determines a 2-phase temporal pattern of viral expression. In the present study, we investigated the Rex dependence of the complete set of alternatively spliced HTLV-1 mRNAs. Analyses of cells transfected with Rex-wild-type and Rex-knockout HTLV-1 molecular clones using splice site-specific quantitative reverse transcription (qRT)-PCR revealed that mRNAs encoding the p30Tof, p13, and p12/8 proteins were Rex dependent, while the p21rex mRNA was Rex independent. These findings provide a rational explanation for the intermediate-late temporal pattern of expression of the p30tof, p13, and p12/8 mRNAs described in previous studies. All the Rex-dependent mRNAs contained a 75-nucleotide intronic region that increased the nuclear retention and degradation of a reporter mRNA in the absence of other viral sequences. Selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) analysis revealed that this sequence formed a stable hairpin structure. Cell cycle synchronization experiments indicated that mitosis partially bypasses the requirement for Rex to export Rex-dependent HTLV-1 transcripts. These findings indicate a link between the cycling properties of the host cell and the temporal pattern of viral expression/latency that might influence the ability of the virus to spread and evade the immune system., Importance: HTLV-1 is a complex retrovirus that causes two distinct pathologies termed adult T-cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy in about 5% of infected individuals. Expression of the virus depends on the concerted action of Tax, which drives transcription of the viral genome, and Rex, which favors expression of incompletely spliced mRNAs and determines a 2-phase temporal pattern of virus expression. The findings reported in this study revealed a novel cis-acting regulatory element and indicated that mitosis partially bypasses the requirement for Rex to export Rex-dependent HTLV-1 transcripts. Our results add a layer of complexity to the mechanisms controlling the expression of alternatively spliced HTLV-1 mRNAs and suggest a link between the cycling properties of the host cell and the temporal pattern of viral expression/latency that might influence the ability of the virus to spread and evade the immune system., (Copyright © 2016, American Society for Microbiology. All Rights Reserved.)
- Published
- 2015
- Full Text
- View/download PDF
21. Identification of novel monocistronic HTLV-1 mRNAs encoding functional Rex isoforms.
- Author
-
Rende F, Cavallari I, Andresen V, Valeri VW, D'Agostino DM, Franchini G, and Ciminale V
- Subjects
- Gene Expression Profiling, Humans, RNA Splicing, RNA, Messenger genetics, Gene Expression Regulation, Viral, Gene Products, rex biosynthesis, Gene Products, rex genetics, Human T-lymphotropic virus 1 genetics, Protein Isoforms biosynthesis, Protein Isoforms genetics, RNA, Messenger analysis
- Abstract
Background: Human T cell leukemia virus type 1 (HTLV-1) gene expression is controlled by the key regulatory proteins Tax and Rex. The concerted action of these proteins results in a two-phase kinetics of viral expression that depends on a time delay between their action. However, it is difficult to explain this delay, as Tax and Rex are produced from the same mRNA. In the present study we investigated whether HTLV-1 may produce novel mRNA species capable of expressing Rex and Tax independently., Findings: Results revealed the expression of three alternatively spliced transcripts coding for novel Rex isoforms in infected cell lines and in primary samples from infected patients. One mRNA coded for a Tax isoform and a Rex isoform, and two mRNAs coded for Rex isoforms but not Tax. Functional assays showed that these Rex isoforms exhibit activity comparable to canonic Rex. An analysis of the temporal expression of these transcripts upon ex vivo culture of cells from infected patients and cell lines transfected with a molecular clone of HTLV-1 revealed early expression of the dicistronic tax/rex mRNAs followed by the monocistronic mRNAs coding for Rex isoforms., Conclusion: The production of monocistronic HTLV-1 mRNAs encoding Rex isoforms with comparable activity to canonical Rex, but with distinct timing, would support a prolonged duration of Rex function with gradual loss of Tax, and is consistent with the two-phase expression kinetics. A thorough understanding of these regulatory circuits will shed light on the basis of viral latency and provide groundwork to develop strategies for eradicating persistent infections.
- Published
- 2015
- Full Text
- View/download PDF
22. Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase.
- Author
-
Ruggero K, Guffanti A, Corradin A, Sharma VK, De Bellis G, Corti G, Grassi A, Zanovello P, Bronte V, Ciminale V, and D'Agostino DM
- Subjects
- Cells, Cultured, Host-Pathogen Interactions, Humans, RNA-Directed DNA Polymerase biosynthesis, CD4-Positive T-Lymphocytes virology, Cell Transformation, Viral, Human T-lymphotropic virus 1 physiology, RNA, Small Untranslated metabolism, RNA, Transfer, Pro metabolism, RNA-Directed DNA Polymerase metabolism, Reverse Transcription
- Abstract
Unlabelled: The present study employed mass sequencing of small RNA libraries to identify the repertoire of small noncoding RNAs expressed in normal CD4(+) T cells compared to cells transformed with human T-cell leukemia virus type 1 (HTLV-1), the causative agent of adult T-cell leukemia/lymphoma (ATLL). The results revealed distinct patterns of microRNA expression in HTLV-1-infected CD4(+) T-cell lines with respect to their normal counterparts. In addition, a search for virus-encoded microRNAs yielded 2 sequences that originated from the plus strand of the HTLV-1 genome. Several sequences derived from tRNAs were expressed at substantial levels in both uninfected and infected cells. One of the most abundant tRNA fragments (tRF-3019) was derived from the 3' end of tRNA-proline. tRF-3019 exhibited perfect sequence complementarity to the primer binding site of HTLV-1. The results of an in vitro reverse transcriptase assay verified that tRF-3019 was capable of priming HTLV-1 reverse transcriptase. Both tRNA-proline and tRF-3019 were detected in virus particles isolated from HTLV-1-infected cells. These findings suggest that tRF-3019 may play an important role in priming HTLV-1 reverse transcription and could thus represent a novel target to control HTLV-1 infection., Importance: Small noncoding RNAs, a growing family of regulatory RNAs that includes microRNAs and tRNA fragments, have recently emerged as key players in many biological processes, including viral infection and cancer. In the present study, we employed mass sequencing to identify the repertoire of small noncoding RNAs in normal T cells compared to T cells transformed with human T-cell leukemia virus type 1 (HTLV-1), a retrovirus that causes adult T-cell leukemia/lymphoma. The results revealed a distinct pattern of microRNA expression in HTLV-1-infected cells and a tRNA fragment (tRF-3019) that was packaged into virions and capable of priming HTLV-1 reverse transcription, a key event in the retroviral life cycle. These findings indicate tRF-3019 could represent a novel target for therapies aimed at controlling HTLV-1 infection.
- Published
- 2014
- Full Text
- View/download PDF
23. Fine tuning of the temporal expression of HTLV-1 and HTLV-2.
- Author
-
Cavallari I, Rende F, Bender C, Romanelli MG, D'Agostino DM, and Ciminale V
- Abstract
Human T-cell leukemia virus types 1 and 2 (HTLV-1 and HTLV-2) are delta retroviruses that share a common overall genetic organization, splicing pattern, and ability to infect and immortalize T-cells in vitro. However, HTLV-1 and HTLV-2 exhibit a clearly distinct pathogenic potential in infected patients. To find clues to the possible viral determinants of the biology of these viruses, recent studies investigated the timing of expression and the intracellular compartmentalization of viral transcripts in ex-vivo samples from infected patients. Results of these studies revealed a common overall pattern of expression of HTLV-1 and -2 with a two-phase kinetics of expression and a nuclear accumulation of minus-strand transcripts. Studies in cells transfected with HTLV-1 molecular clones demonstrated the strict Rex-dependency of this "two-phase" kinetics. These studies also highlighted interesting differences in the relative abundance of transcripts encoding the Tax and Rex regulatory proteins, and that of the accessory proteins controlling Rex expression and function, thus suggesting a potential basis for the different pathobiology of the two viruses.
- Published
- 2013
- Full Text
- View/download PDF
24. Case 1: Recurrent acute liver dysfunction in a 19-month-old boy.
- Author
-
Trakadis YJ, D'Agostino DM, Braverman NE, Lévesque S, and Morinville V
- Published
- 2012
- Full Text
- View/download PDF
25. The microRNA regulatory network in normal- and HTLV-1-transformed T cells.
- Author
-
D'Agostino DM, Zanovello P, Watanabe T, and Ciminale V
- Subjects
- CD4-Positive T-Lymphocytes metabolism, CD4-Positive T-Lymphocytes virology, Cell Line, Cell Transformation, Neoplastic genetics, Cell Transformation, Viral, Gene Expression Regulation, Neoplastic, HTLV-I Infections genetics, HTLV-I Infections pathology, Human T-lymphotropic virus 1 metabolism, Humans, Leukemia-Lymphoma, Adult T-Cell genetics, Leukemia-Lymphoma, Adult T-Cell pathology, Leukemia-Lymphoma, Adult T-Cell virology, RNA, Messenger metabolism, Transcriptome, CD4-Positive T-Lymphocytes pathology, Human T-lymphotropic virus 1 genetics, Human T-lymphotropic virus 1 pathogenicity, MicroRNAs genetics, MicroRNAs metabolism
- Abstract
Recent efforts to understand the molecular networks governing normal T cell development and driving the neoplastic transformation of T cells have brought to light the involvement of microRNAs (miRNAs), a class of noncoding RNAs of approximately 22 nucleotides that regulate gene expression at the posttranscriptional level. In the present review, we compare the expression profiles of miRNAs in normal T cell development to that of transformed T cells using as a model adult T cell leukemia/lymphoma, an aggressive malignancy of mature CD4+ T cells that is caused by infection with human T cell leukemia virus type 1., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
26. Converging strategies in expression of human complex retroviruses.
- Author
-
Cavallari I, Rende F, D'Agostino DM, and Ciminale V
- Subjects
- Gene Expression Regulation, Viral, Genes, Viral, Humans, RNA, Messenger genetics, RNA, Viral metabolism, Retroviridae metabolism, Retroviridae physiology, Retroviridae Infections virology, T-Lymphocytes virology, Viral Nonstructural Proteins genetics, Viral Regulatory and Accessory Proteins genetics, Viral Regulatory and Accessory Proteins metabolism, Virus Replication, Alternative Splicing, RNA, Messenger metabolism, RNA, Viral genetics, Retroviridae genetics, Viral Nonstructural Proteins metabolism
- Abstract
The discovery of human retroviruses in the early 1980s revealed the existence of viral-encoded non-structural genes that were not evident in previously described animal retroviruses. Based on the absence or presence of these additional genes retroviruses were classified as 'simple' and 'complex', respectively. Expression of most of these extra genes is achieved through the generation of alternatively spliced mRNAs. The present review summarizes the genetic organization and expression strategies of human complex retroviruses and highlights the converging mechanisms controlling their life cycles.
- Published
- 2011
- Full Text
- View/download PDF
27. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150.
- Author
-
Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, Mussolin L, Ruggero K, Bonanno L, Guffanti A, De Bellis G, Gerosa G, Stellin G, D'Agostino DM, Basso G, Bronte V, Indraccolo S, Amadori A, and Zanovello P
- Subjects
- 3' Untranslated Regions, Adult, Apoptosis, Cell Line, Cell Line, Tumor, Cell Proliferation, Cells, Cultured, Child, Preschool, Gene Expression Profiling, Genes, Reporter, Humans, Infant, Infant, Newborn, MicroRNAs antagonists & inhibitors, MicroRNAs genetics, Precursor Cell Lymphoblastic Leukemia-Lymphoma metabolism, RNA, Messenger metabolism, Receptor, Notch3, Receptors, Notch antagonists & inhibitors, Receptors, Notch genetics, T-Lymphocyte Subsets cytology, T-Lymphocyte Subsets metabolism, Thymus Gland cytology, Thymus Gland metabolism, Cell Differentiation, Gene Expression Regulation, MicroRNAs metabolism, Receptors, Notch metabolism, T-Lymphocytes cytology, T-Lymphocytes metabolism
- Abstract
Ontogenesis of T cells in the thymus is a complex process whose molecular control is poorly understood. The present study investigated microRNAs involved in human thymocyte differentiation by comparing the microRNA expression profiles of thymocytes at the double-positive, single-positive CD4(+) and single-positive CD8(+) maturation stages. Microarray analysis showed that each thymocyte population displays a distinct microRNA expression profile that reflects their developmental relationships. Moreover, analysis of small-RNA libraries generated from human unsorted and double-positive thymocytes and from mature peripheral CD4(+) and CD8(+) T lymphocytes, together with the microarray data, indicated a trend toward up-regulation of microRNA expression during T-cell maturation after the double-positive stage and revealed a group of microRNAs regulated during normal T-cell development, including miR-150, which is strongly up-regulated as maturation progresses. We showed that miR-150 targets NOTCH3, a member of the Notch receptor family that plays important roles both in T-cell differentiation and leukemogenesis. Forced expression of miR-150 reduces NOTCH3 levels in T-cell lines and has adverse effects on their proliferation and survival. Overall, these findings suggest that control of the Notch pathway through miR-150 may have an important impact on T-cell development and physiology.
- Published
- 2011
- Full Text
- View/download PDF
28. Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs.
- Author
-
Rende F, Cavallari I, Corradin A, Silic-Benussi M, Toulza F, Toffolo GM, Tanaka Y, Jacobson S, Taylor GP, D'Agostino DM, Bangham CR, and Ciminale V
- Subjects
- Cell Compartmentation, Cell Nucleus genetics, Cell Nucleus virology, Gene Expression, Gene Products, rex genetics, Gene Products, rex metabolism, Gene Products, tax genetics, Gene Products, tax metabolism, Genes, Viral, Humans, Kinetics, RNA, Messenger genetics, RNA, Messenger metabolism, RNA, Viral genetics, RNA, Viral metabolism, Retroviridae Proteins, Basic-Leucine Zipper Transcription Factors genetics, HTLV-I Infections genetics, HTLV-I Infections virology, Human T-lymphotropic virus 1 genetics, Viral Proteins genetics
- Abstract
Human T-cell leukemia virus type 1 (HTLV-1) codes for 9 alternatively spliced transcripts and 2 major regulatory proteins named Tax and Rex that function at the transcriptional and posttranscriptional levels, respectively. We investigated the temporal sequence of HTLV-1 gene expression in primary cells from infected patients using splice site-specific quantitative RT-PCR. The results indicated a two-phase kinetics with the tax/rex mRNA preceding expression of other viral transcripts. Analysis of mRNA compartmentalization in cells transfected with HTLV-1 molecular clones demonstrated the strict Rex-dependency of the two-phase kinetics and revealed strong nuclear retention of HBZ mRNAs, supporting their function as noncoding transcripts. Mathematical modeling underscored the importance of a delay between the functions of Tax and Rex, which was supported by experimental evidence of the longer half-life of Rex. These data provide evidence for a temporal pattern of HTLV-1 expression and reveal major differences in the intracellular compartmentalization of HTLV-1 transcripts.
- Published
- 2011
- Full Text
- View/download PDF
29. HTLV-1 p13, a small protein with a busy agenda.
- Author
-
Silic-Benussi M, Biasiotto R, Andresen V, Franchini G, D'Agostino DM, and Ciminale V
- Subjects
- Cell Nucleus metabolism, Gene Products, tax metabolism, Humans, Mitochondria metabolism, Protein Binding, Viral Proteins chemistry, Human T-lymphotropic virus 1 metabolism, Viral Proteins metabolism
- Abstract
Human T-cell leukemia virus type 1 (HTLV-1) infection is characterized by life-long persistence of the virus in the host. While most infected individuals remain asymptomatic, 3-5% will eventually develop adult T-cell leukemia/lymphoma (ATLL) or tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM) after a clinical latency that can span years (TSP/HAM) to decades (ATLL). The major oncogenic determinant among HTLV-1 proteins is the Tax transactivator, which influences the expression and function of a great number of cellular proteins, drives cell proliferation, reduces cell death, and induces genetic instability. The present review is focused on the current knowledge of p13, an HTLV-1 accessory protein targeted to the inner mitochondrial membrane and, under certain conditions, to the nucleus. In mitochondria, p13 produces an inward K+current that results in an increased production of ROS by mitochondria. These effects are linked to the protein's effects on cell turnover which include activation of primary T-cells and reduced proliferation/sensitization to death of tumor cells. Recent findings suggest that in the presence of Tax, p13 is subjected to ubiquitylation and partly targeted to the nucleus. Nuclear p13 binds Tax and inhibits its transcriptional activity. These findings suggest that the protein might exert distinct functions depending on its intracellular localization and influence both the turnover of infected cells and the balance between viral latency and productive infection., (Copyright © 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
30. Role of microRNAs in HTLV-1 infection and transformation.
- Author
-
Ruggero K, Corradin A, Zanovello P, Amadori A, Bronte V, Ciminale V, and D'Agostino DM
- Subjects
- Cell Transformation, Neoplastic pathology, Gene Expression Regulation, Leukemic genetics, HTLV-I Infections pathology, Human T-lymphotropic virus 1 genetics, Humans, Leukemia-Lymphoma, Adult T-Cell genetics, Leukemia-Lymphoma, Adult T-Cell pathology, MicroRNAs genetics, Cell Transformation, Neoplastic genetics, HTLV-I Infections genetics, Human T-lymphotropic virus 1 pathogenicity, Human T-lymphotropic virus 1 physiology, MicroRNAs metabolism
- Abstract
Human T-cell leukemia virus type 1 (HTLV-1), a retrovirus that infects more than 20 million people worldwide, is the etiological agent of ATLL (adult T-cell leukemia/lymphoma), an aggressive leukemia of CD4+ T lymphocytes which arises in a small percentage of infected individuals after a long clinical latency. Tumor emergence is attributed primarily to the oncogenic activity of the viral protein Tax, which drives the expression of viral transcripts and controls the expression and function of a broad variety of host-cell genes involved in proliferation, genetic stability and apoptosis. Nevertheless, many aspects of HTLV-1 replication, persistence and pathogenesis remain to be understood. The emerging role of microRNAs in tumor development and viral infection has prompted investigations on the interactions between HTLV-1 and the microRNA regulatory network. In the present review we discuss recent data demonstrating changes in cellular microRNA expression in HTLV-1-infected cell lines and ATLL cells, and the functional impact of a subset microRNAs deregulated by HTLV-1 on cellular gene expression and signal transduction pathways. Mechanisms through which the viral proteins may influence microRNA expression are discussed. Results of searches for potential cellular microRNAs that target viral transcripts and for microRNAs produced by HTLV-1 are described. Observations along with regarding the expression of tRNA-derived small regulatory RNAs in HTLV-1-infected cells are presented., (Copyright © 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
31. Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: distinct effects in primary versus transformed cells.
- Author
-
Silic-Benussi M, Cavallari I, Vajente N, Vidali S, Chieco-Bianchi L, Di Lisa F, Saggioro D, D'Agostino DM, and Ciminale V
- Subjects
- Cell Line, Cells, Cultured, Gene Expression Regulation, Viral, Genetic Vectors genetics, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, HeLa Cells, Host-Pathogen Interactions, Human T-lymphotropic virus 1 physiology, Humans, Jurkat Cells, Lentivirus genetics, Microscopy, Confocal, Mitochondria metabolism, Oxidation-Reduction, RNA Interference, Retroviridae Proteins genetics, Reverse Transcriptase Polymerase Chain Reaction, T-Lymphocytes cytology, T-Lymphocytes virology, Transduction, Genetic, Human T-lymphotropic virus 1 metabolism, Reactive Oxygen Species metabolism, Retroviridae Proteins metabolism, T-Lymphocytes metabolism
- Abstract
The present study investigated the function of p13, a mitochondrial protein of human T-cell leukemia virus type 1 (HTLV-1). Although necessary for viral propagation in vivo, the mechanism of function of p13 is incompletely understood. Drawing from studies in isolated mitochondria, we analyzed the effects of p13 on mitochondrial reactive oxygen species (ROS) in transformed and primary T cells. In transformed cells (Jurkat, HeLa), p13 did not affect ROS unless the cells were subjected to glucose deprivation, which led to a p13-dependent increase in ROS and cell death. Using RNA interference we confirmed that expression of p13 also influences glucose starvation-induced cell death in the context of HTLV-1-infected cells. ROS measurements showed an increasing gradient from resting to mitogen-activated primary T cells to transformed T cells (Jurkat). Expression of p13 in primary T cells resulted in their activation, an effect that was abrogated by ROS scavengers. These findings suggest that p13 may have a distinct impact on cell turnover depending on the inherent ROS levels; in the context of the HTLV-1 propagation strategy, p13 could increase the pool of "normal" infected cells while culling cells acquiring a transformed phenotype, thus favoring lifelong persistence of the virus in the host.
- Published
- 2010
- Full Text
- View/download PDF
32. The p13 protein of human T cell leukemia virus type 1 (HTLV-1) modulates mitochondrial membrane potential and calcium uptake.
- Author
-
Biasiotto R, Aguiari P, Rizzuto R, Pinton P, D'Agostino DM, and Ciminale V
- Subjects
- Calcium Signaling, HeLa Cells, Human T-lymphotropic virus 1 genetics, Human T-lymphotropic virus 1 pathogenicity, Humans, Ion Transport, Models, Biological, Mutagenesis, Site-Directed, Mutant Proteins chemistry, Mutant Proteins genetics, Mutant Proteins metabolism, Protein Structure, Tertiary, Recombinant Fusion Proteins chemistry, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins metabolism, Retroviridae Proteins chemistry, Retroviridae Proteins genetics, Transfection, Calcium metabolism, Human T-lymphotropic virus 1 metabolism, Membrane Potential, Mitochondrial, Retroviridae Proteins metabolism
- Abstract
Human T cell leukemia virus type 1 (HTLV-1) encodes p13, an 87-amino-acid protein that accumulates in the inner mitochondrial membrane. Recent studies performed using synthetic p13 and isolated mitochondria demonstrated that the protein triggers an inward potassium (K+) current and inner membrane depolarization. The present study investigated the effects of p13 on mitochondrial inner membrane potential (Deltapsi) in living cells. Using the potential-dependent probe tetramethyl rhodamine methyl ester (TMRM), we observed that p13 induced dose-dependent mitochondrial depolarization in HeLa cells. This effect was abolished upon mutation of 4 arginines in p13's alpha-helical domain that were previously shown to be essential for its activity in in vitro assays. As Deltapsi is known to control mitochondrial calcium (Ca2+) uptake, we next analyzed the effect of p13 on Ca2+ homeostasis. Experiments carried out in HeLa cells expressing p13 and organelle-targeted aequorins revealed that the protein specifically reduced mitochondrial Ca2+ uptake. These observations suggest that p13 might control key processes regulated through Ca2+ signaling such as activation and death of T cells, the major targets of HTLV-1 infection., (Copyright © 2010 Elsevier B.V. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
33. Effects of human T-cell leukemia virus type 1 (HTLV-1) p13 on mitochondrial K+ permeability: A new member of the viroporin family?
- Author
-
Silic-Benussi M, Marin O, Biasiotto R, D'Agostino DM, and Ciminale V
- Subjects
- Amino Acid Sequence, Animals, Cell Transformation, Viral drug effects, Humans, Molecular Sequence Data, Permeability drug effects, Retroviridae Proteins chemistry, Retroviridae Proteins metabolism, Human T-lymphotropic virus 1, Mitochondria drug effects, Mitochondria metabolism, Potassium metabolism, Retroviridae Proteins pharmacology
- Abstract
Human T-cell leukemia virus type-1 (HTLV-1) encodes a mitochondrial protein named p13. p13 mediates an inward K(+) current in isolated mitochondria that leads to mitochondrial swelling, depolarization, increased respiratory chain activity and reactive oxygen species (ROS) production. These effects trigger the opening of the permeability transition pore and are dependent on the presence of K(+) and on the amphipathic alpha helical domain of p13. In the context of cells, p13 acts as a sensitizer to selected apoptotic stimuli. Although it is not known whether p13 influences the activity of endogenous K(+) channels or forms a channel itself, it shares some structural and functional analogies with viroporins, a class of small integral membrane proteins that form pores and alter membrane permeability., (Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
34. Modulation of mitochondrial K(+) permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1.
- Author
-
Silic-Benussi M, Cannizzaro E, Venerando A, Cavallari I, Petronilli V, La Rocca N, Marin O, Chieco-Bianchi L, Di Lisa F, D'Agostino DM, Bernardi P, and Ciminale V
- Subjects
- Calcium pharmacology, Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone pharmacology, Humans, Ionophores pharmacology, Membrane Potential, Mitochondrial drug effects, Mitochondria drug effects, Mitochondria ultrastructure, Mitochondrial Permeability Transition Pore, Mitochondrial Swelling drug effects, Models, Biological, Permeability, Potassium Channels metabolism, Valinomycin pharmacology, Human T-lymphotropic virus 1 genetics, Human T-lymphotropic virus 1 metabolism, Mitochondria metabolism, Mitochondrial Membrane Transport Proteins metabolism, Potassium metabolism, Reactive Oxygen Species metabolism
- Abstract
Human T-cell leukemia virus type-1 (HTLV-1) expresses an 87-amino acid protein named p13 that is targeted to the inner mitochondrial membrane. Previous studies showed that a synthetic peptide spanning an alpha helical domain of p13 alters mitochondrial membrane permeability to cations, resulting in swelling. The present study examined the effects of full-length p13 on isolated, energized mitochondria. Results demonstrated that p13 triggers an inward K(+) current that leads to mitochondrial swelling and confers a crescent-like morphology distinct from that caused by opening of the permeability transition pore. p13 also induces depolarization, with a matching increase in respiratory chain activity, and augments production of reactive oxygen species (ROS). These effects require an intact alpha helical domain and strictly depend on the presence of K(+) in the assay medium. The effects of p13 on ROS are mimicked by the K(+) ionophore valinomycin, while the protonophore FCCP decreases ROS, indicating that depolarization induced by K(+) vs. H(+) currents has different effects on mitochondrial ROS production, possibly because of their opposite effects on matrix pH (alkalinization and acidification, respectively). The downstream consequences of p13-induced mitochondrial K(+) permeability are likely to have an important influence on the redox state and turnover of HTLV-1-infected cells.
- Published
- 2009
- Full Text
- View/download PDF
35. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
- Author
-
Cavallari I, Silic-Benussi M, Rende F, Martines A, Fogar P, Basso D, Vella MD, Pedrazzoli S, Herman JG, Chieco-Bianchi L, Esposito G, Ciminale V, and D'Agostino DM
- Subjects
- Aged, Base Sequence, Carcinoma, Pancreatic Ductal metabolism, Cell Cycle, Cell Line, Tumor, Epigenesis, Genetic, Female, Fluorescent Antibody Technique, Humans, Loss of Heterozygosity, Male, Middle Aged, Molecular Sequence Data, Multivariate Analysis, Pancreas, Exocrine cytology, Pancreas, Exocrine metabolism, Pancreatic Ducts cytology, Pancreatic Ducts metabolism, Pancreatic Neoplasms metabolism, Polymerase Chain Reaction, Proportional Hazards Models, Proto-Oncogene Proteins metabolism, Carcinoma, Pancreatic Ductal genetics, DNA Methylation, Gene Expression Regulation, Neoplastic, Pancreatic Neoplasms genetics, Promoter Regions, Genetic, Proto-Oncogene Proteins genetics
- Abstract
Loss of menin, a tumor suppressor coded by the MEN1 gene, is a key factor in the pathogenesis of multiple endocrine neoplasia type I and in a percentage of sporadic endocrine tumors of the pancreas and parathyroid glands. This study investigated expression of the menin protein in the normal exocrine pancreas and in pancreatic ductal adenocarcinoma (PDAC), the most common pancreatic tumor. Immunofluorescence (IF) analyses showed that menin is expressed at high levels in normal acinar and duct cells. Examination of 24 clinical samples of PDAC revealed a pronounced decrease in menin expression in all tumors examined. To identify alterations underlying this defect, we searched for disruption and epigenetic silencing of the MEN1 gene. Analysis of nine laser-microdissected tumors revealed loss of heterozygosity of intragenic (one tumor) or adjacent (three tumors) MEN1 microsatellite markers. Methylation of CpG sites in the MEN1 promoter was documented in five of 24 tumors. IF analyses also revealed low to undetectable menin expression in the PDAC cell lines MiaPaCa-2 and Panc-1. Ectopic expression of menin in these cells resulted in a marked alteration of the cell cycle, with an increase in the G1/S+G2 ratio. These findings represent the first evidence that the MEN1 gene is a target of mutation and methylation in PDAC and that menin influences the cell cycle profile of duct cells., (Copyright 2009 Wiley-Liss,Inc.)
- Published
- 2009
- Full Text
- View/download PDF
36. Control of cell death pathways by HTLV-1 proteins.
- Author
-
Saggioro D, Silic-Benussi M, Biasiotto R, D'Agostino DM, and Ciminale V
- Subjects
- Cell Proliferation, Cell Survival, Homeostasis, Humans, Cell Death physiology, Human T-lymphotropic virus 1 metabolism, Leukemia-Lymphoma, Adult T-Cell pathology, Viral Proteins physiology
- Abstract
Individuals infected with HTLV-1 harbor the virus mainly in CD4+ memory T-cells as a lifelong infection that remains subclinical in the majority of cases. However, about 3-5% of HTLV-1-infected individuals develop an aggressive T-cell neoplasia (ATLL) or a neurodegenerative disease (TSP/HAM) after a latency period ranging from years to decades. This review summarizes the current knowledge of the effects of the HTLV-1 proteins Tax, p13 and p12 on cell death and survival pathways. Tax, the major oncogenic determinant of HTLV-1, enhances cell survival through its effects on the NF-kappaB, CREB and AKT pathways and on the tumor suppressors p53 and Rb. p13 is targeted to the inner mitochondrial membrane and sensitizes cells to the Fas/ceramide apoptotic pathway and reactive oxygen species-mediated cell death. p12 enhances release of calcium from the endoplasmic reticulum and therefore may influence calcium-dependent apoptotic signals, including opening of the mitochondrial permeability transition pore. The long-term fate of HTLV-1-infected cells (apoptosis, survival, transformation) may therefore depend on the balance of the effects of Tax, p13 and p12 on cell death pathways.
- Published
- 2009
- Full Text
- View/download PDF
37. The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth.
- Author
-
D'Agostino DM, Silic-Benussi M, Hiraragi H, Lairmore MD, and Ciminale V
- Subjects
- Amino Acid Sequence, Animals, Apoptosis drug effects, Calcium metabolism, Cell Death drug effects, Cell Proliferation drug effects, Cloning, Molecular, Humans, Intracellular Membranes drug effects, Mitochondria physiology, Molecular Sequence Data, Retroviridae Proteins biosynthesis, Retroviridae Proteins genetics, Signal Transduction drug effects, Human T-lymphotropic virus 1 genetics, Human T-lymphotropic virus 1 metabolism, Mitochondria drug effects, Retroviridae Proteins pharmacology
- Abstract
p13(II) of human T-cell leukemia virus type 1 (HTLV-1) is an 87-amino-acid protein that is targeted to the inner mitochondrial membrane. p13(II) alters mitochondrial membrane permeability, producing a rapid, membrane potential-dependent influx of K(+). These changes result in increased mitochondrial matrix volume and fragmentation and may lead to depolarization and alterations in mitochondrial Ca(2+) uptake/retention capacity. At the cellular level, p13(II) has been found to interfere with cell proliferation and transformation and to promote apoptosis induced by ceramide and Fas ligand. Assays carried out in T cells (the major targets of HTLV-1 infection in vivo) demonstrate that p13(II)-mediated sensitization to Fas ligand-induced apoptosis can be blocked by an inhibitor of Ras farnesylation, thus implicating Ras signaling as a downstream target of p13(II) function.
- Published
- 2005
- Full Text
- View/download PDF
38. Mitochondria as functional targets of proteins coded by human tumor viruses.
- Author
-
D'Agostino DM, Bernardi P, Chieco-Bianchi L, and Ciminale V
- Subjects
- Animals, Humans, Mitochondria virology, Oncogenic Viruses physiology, Viral Proteins physiology
- Abstract
Molecular analyses of tumor virus-host cell interactions have provided key insights into the genes and pathways involved in neoplastic transformation. Recent studies have revealed that the human tumor viruses Epstein-Barr virus (EBV), Kaposi's sarcoma-associated herpesvirus (KSHV), human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV), and human T-cell leukemia virus type 1 (HTLV-1) express proteins that are targeted to mitochondria. The list of these viral proteins includes BCL-2 homologues (BHRF1 of EBV; KSBCL-2 of KSHV), an inhibitor of apoptosis (IAP) resembling Survivin (KSHV K7), proteins that alter mitochondrial ion permeability and/or membrane potential (HBV HBx, HPV E[wedge]14, HCV p7, and HTLV-1 p13(II)), and K15 of KSHV, a protein with undefined function. Consistent with the central role of mitochondria in energy production, cell death, calcium homeostasis, and redox balance, experimental evidence indicates that these proteins have profound effects on host cell physiology. In particular, the viral BCL-2 homologues BHRF1 and KSBCL-2 inhibit apoptosis triggered by a variety of stimuli. HBx, p7, E1[wedge]4, and p13(II) exert powerful effects on mitochondria either directly due to their channel-forming activity or indirectly through interactions with endogenous channels. Further investigation of these proteins and their interactions with mitochondria will provide important insights into the mechanisms of viral replication and tumorigenesis and could aid in the discovery of new targets for anti-tumor therapy.
- Published
- 2005
- Full Text
- View/download PDF
39. Differential expression of menin in sporadic pituitary adenomas.
- Author
-
Theodoropoulou M, Cavallari I, Barzon L, D'Agostino DM, Ferro T, Arzberger T, Grübler Y, Schaaf L, Losa M, Fallo F, Ciminale V, Stalla GK, and Pagotto U
- Subjects
- Adenoma pathology, Adolescent, Adult, Aged, Aged, 80 and over, Female, Genes, Tumor Suppressor, Humans, Immunoenzyme Techniques, Male, Middle Aged, Pituitary Gland metabolism, Pituitary Gland pathology, Pituitary Neoplasms pathology, Adenoma metabolism, Neoplasm Invasiveness pathology, Pituitary Neoplasms metabolism, Proto-Oncogene Proteins metabolism
- Abstract
Pituitary adenomas represent one of the key features of multiple endocrine neoplasia type 1. The gene involved in this syndrome (MEN1) is a putative tumor suppressor, that codes for a 610-amino acid nuclear protein termed 'menin'. Analyses of sporadic pituitary adenomas have so far failed to reveal MEN1 mutations or defects in MEN1 transcription in these tumors. In the present study we detected menin protein expression in a panel of normal and tumoral pituitary tissues, using a monoclonal antibody against the carboxy-terminus of menin. In the normal human pituitary gland, strong nuclear staining for menin was detectable in the majority of the endocrine cells of the anterior lobe, without a clear association with a particular hormone-producing type. In sporadic pituitary adenomas, menin expression was variable, with a high percentage of cases demonstrating a significant decrease in menin immunoreactivity when compared with the normal pituitary. Interestingly, metastatic tissues derived from one pituitary carcinoma had no detectable menin levels. Altogether, our data provide the first information regarding the status of menin expression in human normal and neoplastic pituitary as determined by immunohistochemistry (IHC)., (Copyright 2004 Society for Endocrinology)
- Published
- 2004
- Full Text
- View/download PDF
40. Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1.
- Author
-
Silic-Benussi M, Cavallari I, Zorzan T, Rossi E, Hiraragi H, Rosato A, Horie K, Saggioro D, Lairmore MD, Willems L, Chieco-Bianchi L, D'Agostino DM, and Ciminale V
- Subjects
- Base Sequence, Blotting, Western, Cell Cycle physiology, DNA Primers, Fluorescent Antibody Technique, HeLa Cells, Human T-lymphotropic virus 1 metabolism, Humans, Jurkat Cells, Retroviridae Proteins metabolism, Cell Division physiology, Human T-lymphotropic virus 1 physiology, Mitochondria metabolism, Retroviridae Proteins physiology
- Abstract
Human T cell leukemia virus type 1 encodes an "accessory" protein named p13(II) that is targeted to mitochondria and triggers a rapid flux of K(+) and Ca(2+) across the inner membrane. In this study, we investigated the effects of p13(II) on tumorigenicity in vivo and on cell growth in vitro. Results showed that p13(II) significantly reduced the incidence and growth rate of tumors arising from c-myc and Ha-ras-cotransfected rat embryo fibroblasts. Consistent with these findings, HeLa-derived cell lines stably expressing p13(II) exhibited markedly reduced tumorigenicity, as well as reduced proliferation at high density in vitro. Mixed culture assays revealed that the phenotype of the p13(II) cell lines was dominant over that of control lines and was mediated by a heat-labile soluble factor. The p13(II) cell lines exhibited an enhanced response to Ca(2+)-mediated stimuli, as measured by increased sensitivity to C2-ceramide-induced apoptosis and by cAMP-responsive element-binding protein (CREB) phosphorylation in response to histamine. p13(II)-expressing Jurkat T cells also exhibited reduced proliferation, suggesting that the protein might exert similar effects in T cells, the primary target of HTLV-1 infection. These findings provide clues into the function of p13(II) as a negative regulator of cell growth and underscore a link between mitochondria, Ca(2+) signaling, and tumorigenicity.
- Published
- 2004
- Full Text
- View/download PDF
41. Functional domain structure of human T-cell leukemia virus type 2 rex.
- Author
-
Narayan M, Younis I, D'Agostino DM, and Green PL
- Subjects
- Base Sequence, Biopolymers, Cell Line, DNA Primers, Fluorescent Antibody Technique, Indirect, Gene Products, rex chemistry, Gene Products, rex genetics, Human T-lymphotropic virus 2 physiology, Humans, Mutation, Phosphorylation, Protein Conformation, Reverse Transcriptase Polymerase Chain Reaction, Subcellular Fractions metabolism, Gene Products, rex metabolism
- Abstract
The Rex protein of human T-cell leukemia virus (HTLV) acts posttranscriptionally to induce the cytoplasmic expression of the unspliced and incompletely spliced viral RNAs encoding the viral structural and enzymatic proteins and is therefore essential for efficient viral replication. Rex function requires nuclear import, RNA binding, multimerization, and nuclear export. In addition, it has been demonstrated that the phosphorylation status of HTLV-2 Rex (Rex-2) correlates with RNA binding and inhibition of splicing in vitro. Recent mutational analyses of Rex-2 revealed that the phosphorylation of serine residues 151 and 153 within a novel carboxy-terminal domain is critical for function in vivo. To further define the functional domain structure of Rex-2, we evaluated a panel of Rex-2 mutants for subcellular localization, RNA binding capacity, multimerization and trans-dominant properties, and the ability to shuttle between the nucleus and the cytoplasm. Rex-2 mutant S151A,S153A, which is defective in phosphorylation and function, showed diffuse cytoplasmic staining, whereas mutant S151D,S153D, previously shown to be functional and in a conformation corresponding to constitutive phosphorylation, displayed increased intense speckled staining in the nucleoli. In vivo RNA binding analyses indicated that mutant S151A,S153A failed to efficiently bind target RNA, while its phosphomimetic counterpart, S151D,S153D, bound twofold more RNA than wild-type Rex-2. Taken together, these findings provide direct evidence that the phosphorylation status of Rex-2 is linked to cellular trafficking and RNA binding capacity. Mutants with substitutions in either of the two putative multimerization domains or in the putative activation domain-nuclear export signal displayed a dominant negative phenotype as well as defects in multimerization and nucleocytoplasmic shuttling. Several carboxy-terminal mutants that displayed wild-type levels of phosphorylation and localized to the nucleolus were also partially impaired in shuttling. This is consistent with the hypothesis that the carboxy terminus of Rex-2 contains a novel domain that is required for efficient shuttling. This work thus provides a more detailed functional domain map of Rex-2 and further insight into its regulation of HTLV replication.
- Published
- 2003
- Full Text
- View/download PDF
42. In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells.
- Author
-
Cavallari I, D'Agostino DM, Ferro T, Rosato A, Barzon L, Pasquali C, Fogar P, Theodoropoulou M, Esposito G, Boscaro M, Pagotto U, Tebaldi E, Fallo F, Chieco-Bianchi L, and Ciminale V
- Subjects
- Aged, Antibodies, Monoclonal, DNA genetics, Diabetes Mellitus, Type 2 metabolism, Fluorescent Antibody Technique, Indirect, Gastrinoma metabolism, Humans, Immunoblotting, Immunohistochemistry, Insulinoma metabolism, Islets of Langerhans cytology, Male, Microscopy, Confocal, Neoplasm Proteins genetics, Pancreas cytology, Islets of Langerhans metabolism, Neoplasm Proteins analysis, Pancreas metabolism, Pancreatic Neoplasms metabolism, Proto-Oncogene Proteins
- Abstract
Multiple endocrine neoplasia type 1 (MEN1) is a hereditary syndrome linked to mutations in the MEN1 gene, which encodes a 610-amino-acid nuclear protein termed menin. Because of the lack of a suitable detection protocol, the in situ expression pattern of menin in human tissues remains to be determined. In this study, we have developed an antimenin monoclonal antibody and an indirect immunofluorescence/laser-scanning microscopy protocol for analyzing menin expression in frozen tissue sections. Because neuroendocrine pancreatic tumors represent a key feature of MEN1, we focused this study on nontumoral pancreas and a small panel of neuroendocrine pancreatic tumors. Results showed that menin was readily detected in nontumoral exocrine cells. In contrast, most islet cells expressing insulin, glucagon, or somatostatin showed considerably weaker levels of menin expression; however, a subpopulation of pancreatic polypeptide-positive cells exhibited a signal comparable with that detected in adjacent exocrine cells. Sporadic endocrine tumors showed variable levels of menin expression, whereas a MEN1-/- gastrinoma scored negative. This report thus provides the first description of the expression pattern of menin in human pancreas in situ and lays the groundwork for further studies of other tissues and tumors.
- Published
- 2003
- Full Text
- View/download PDF
43. Mitochondrial alterations induced by the p13II protein of human T-cell leukemia virus type 1. Critical role of arginine residues.
- Author
-
D'Agostino DM, Ranzato L, Arrigoni G, Cavallari I, Belleudi F, Torrisi MR, Silic-Benussi M, Ferro T, Petronilli V, Marin O, Chieco-Bianchi L, Bernardi P, and Ciminale V
- Subjects
- Amino Acid Sequence, Arginine, Humans, Membrane Potentials, Mitochondria chemistry, Mitochondria physiology, Molecular Sequence Data, Peptide Fragments physiology, Protein Folding, Protein Structure, Secondary, Retroviridae Proteins analysis, Retroviridae Proteins chemistry, Structure-Activity Relationship, Human T-lymphotropic virus 1 chemistry, Mitochondrial Swelling, Retroviridae Proteins physiology
- Abstract
Human T-cell leukemia virus type 1 encodes a number of "accessory" proteins of unclear function; one of these proteins, p13(II), is targeted to mitochondria and disrupts mitochondrial morphology. The present study was undertaken to unravel the function of p13(II) through (i) determination of its submitochondrial localization and sequences required to alter mitochondrial morphology and (ii) an assessment of the biophysical and biological properties of synthetic peptides spanning residues 9-41 (p13(9-41)), which include the amphipathic mitochondrial-targeting sequence of the protein. p13(9-41) folded into an alpha helix in micellar environments. Fractionation and immunogold labeling indicated that full-length p13(II) accumulates in the inner mitochondrial membrane. p13(9-41) induced energy-dependent swelling of isolated mitochondria by increasing inner membrane permeability to small cations (Na(+), K(+)) and released Ca(2+) from Ca(2+)-preloaded mitochondria. These effects as well as the ability of full-length p13(II) to alter mitochondrial morphology in cells required the presence of four arginines, forming the charged face of the targeting signal. The mitochondrial effects of p13(9-41) were insensitive to cyclosporin A, suggesting that full-length p13(II) might alter mitochondrial permeability through a permeability transition pore-independent mechanism, thus distinguishing it from the mitochondrial proteins Vpr and X of human immunodeficiency virus type 1 and hepatitis B virus, respectively.
- Published
- 2002
- Full Text
- View/download PDF
44. Expression and functional properties of proteins encoded in the x-II ORF of HTLV-I.
- Author
-
D'Agostino DM, Zotti L, Ferro T, Cavallori I, Silic-Benussi M, Chieco-Bianchi L, and Ciminale V
- Subjects
- Amino Acid Sequence, Gene Expression, Human T-lymphotropic virus 1 metabolism, Mitochondria metabolism, Molecular Sequence Data, Open Reading Frames, RNA Splicing, RNA, Messenger metabolism, RNA-Binding Proteins metabolism, Retroviridae Proteins metabolism, Genes, pX physiology, Human T-lymphotropic virus 1 genetics, Retroviridae Proteins genetics
- Abstract
With the aim of identifying viral proteins that contribute to the distinctive properties of HTLV-I biology and pathogenicity, several laboratories have investigated the coding potential of the X region of the genome, which includes five partially overlapping open reading frames (ORFs). We and others have shown that, in addition to the essential regulatory proteins Rex and Tax, a number of accessory proteins encoded in the X region can be produced by alternative splicing and multicistronic translation. One X region ORF, termed X-II, produces two protein isoforms named Tof/p30II and p13II, which are expressed from a doubly- and singly-spliced mRNA, respectively. Initial functional analyses demonstrated that Tof/p30II is a nucleolar/nuclear protein that possesses a region capable of binding to RNA, and p13II is a mitochondrial protein that alters the morphology and function of this organelle. Together with data from other laboratories demonstrating the production of antibodies and CTL against x-II ORF products in HTLV-I infected subjects and the requirement of this ORF for efficient viral replication in vivo, these findings suggest that further characterization of Tof/p30II and p13II will yield insight into remaining undefined aspects of HTLV-I pathogenicity and replication.
- Published
- 2001
- Full Text
- View/download PDF
45. Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.
- Author
-
D'Agostino DM, Ferro T, Zotti L, Meggio F, Pinna LA, Chieco-Bianchi L, and Ciminale V
- Subjects
- Amino Acid Sequence, Biological Transport, Cell Nucleus genetics, Cell Nucleus metabolism, Gene Products, rev metabolism, HeLa Cells, Humans, Molecular Sequence Data, Nuclear Proteins metabolism, Serine-Arginine Splicing Factors, Signal Transduction, Structure-Activity Relationship, Virus Replication genetics, rev Gene Products, Human Immunodeficiency Virus, Acquired Immunodeficiency Syndrome virology, Gene Products, rev genetics, Genes, rev, HIV-1 physiology, Nuclear Proteins genetics, Ribonucleoproteins
- Abstract
The activity of human immunodeficiency virus Rev as a regulator of viral mRNA expression is tightly linked to its ability to shuttle between the nucleus and cytoplasm; these properties are conferred by a leucine-rich nuclear export signal (NES) and by an arginine-rich nuclear localization signal/RNA binding domain (NLS/RBD) required for binding to the Rev-responsive element (RRE) located on viral unspliced and singly spliced mRNAs. Structure predictions and biophysical measurements indicate that Rev consists of an unstructured region followed by a helix-loop-helix motif containing the NLS/RBD and sequences directing multimerization and by a carboxy-terminal tail containing the NES. We present evidence that the loop portion of the helix-loop-helix region is an essential functional determinant that is required for binding to the RRE and for correct intracellular routing. Data obtained using a protein kinase CK2 phosphorylation assay indicated that the loop region is essential for juxtaposition of helices 1 and 2 and phosphorylation by protein kinase CK2. Deletion of the loop resulted in partial accumulation of Rev in SC35-positive nuclear bodies that resembled nuclear bodies that form in response to inhibition of transcription. Accumulation of the DeltaLoop mutant in nuclear bodies depended on the presence of an intact NES, suggesting that both the loop and the NES play a role in controlling intranuclear compartmentalization of Rev and its association with splicing factors.
- Published
- 2000
- Full Text
- View/download PDF
46. The p13II protein of HTLV type 1: comparison with mitochondrial proteins coded by other human viruses.
- Author
-
D'Agostino DM, Zotti L, Ferro T, Franchini G, Chieco-Bianchi L, and Ciminale V
- Subjects
- HTLV-I Infections physiopathology, HTLV-I Infections virology, Humans, Viral Proteins genetics, Viral Proteins metabolism, Virus Diseases physiopathology, Virus Diseases virology, Virus Replication physiology, Viruses growth & development, Human T-lymphotropic virus 1 physiology, Mitochondria metabolism, Retroviridae Proteins genetics, Retroviridae Proteins metabolism, Viruses metabolism
- Abstract
In addition to the essential regulatory proteins Rex and Tax, the HTLV-1 genome encodes several accessory proteins of yet undefined function. One of these "orphan" proteins, named p13(II), was recently shown to be selectively targeted to mitochondria and to induce specific changes in mitochondrial morphology suggestive of altered inner membrane permeability and swelling. This represented the first report of a retroviral gene product targeted to mitochondria, and suggested that p13(II)-induced alterations in the function of this organelle may play a role in HTLV-1 replication and/or pathogenesis. The more recent findings that both Vpr and Tat of HIV-1 are targeted to mitochondria reinforces the proposed relevance of mitochondrial metabolism to the life cycle of retroviruses. Thus, p13(II), Vpr, and Tat can be added to the growing list of mitochondrial proteins produced by clinically important human viruses, including Epstein-Barr virus, human cytomegalovirus, and hepatitis B virus. Mitochondria are known to play a critical role by providing an amplification loop required for the execution of signaling pathways leading to programmed cell death. The functional consequences of the interactions between viral proteins and mitochondria described so far have been attributed to either the positive or negative control of apoptotic responses mediated by this organelle. Further analysis of the effects of p13(II) on mitochondrial function is likely to add to our understanding of the mechanisms underlying the development of HTLV-1-associated diseases.
- Published
- 2000
- Full Text
- View/download PDF
47. Unique features of HIV-1 Rev protein phosphorylation by protein kinase CK2 ('casein kinase-2').
- Author
-
Marin O, Sarno S, Boschetti M, Pagano MA, Meggio F, Ciminale V, D'Agostino DM, and Pinna LA
- Subjects
- Amino Acid Sequence, Calmodulin chemistry, Calmodulin metabolism, Casein Kinase II, Catalytic Domain, Dose-Response Relationship, Drug, Gene Products, rev chemistry, Gene Products, rev genetics, Helix-Loop-Helix Motifs, Heparin pharmacology, Holoenzymes chemistry, Holoenzymes metabolism, Humans, Kinetics, Molecular Sequence Data, Mutation genetics, Peptide Fragments chemistry, Peptide Fragments metabolism, Phosphorylation drug effects, Phosphoserine metabolism, Protein Conformation, Protein Serine-Threonine Kinases antagonists & inhibitors, Protein Serine-Threonine Kinases chemistry, Recombinant Fusion Proteins chemistry, Recombinant Fusion Proteins metabolism, Spermine pharmacology, rev Gene Products, Human Immunodeficiency Virus, Gene Products, rev metabolism, HIV-1, Protein Serine-Threonine Kinases metabolism
- Abstract
The HIV-1 Rev transactivator is phosphorylated in vitro by protein kinase CK2 at two residues, Ser-5 and Ser-8; these sites are also phosphorylated in vivo. Here we show that the mechanism by which CK2 phosphorylates Rev is unique in several respects, notably: (i) it is fully dependent on the regulatory, beta-subunit of CK2; (ii) it relies on the integrity of an acidic stretch of CK2 beta which down-regulates the phosphorylation of other substrates; (iii) it is inhibited in a dose-dependent manner by polyamines and other polycationic effectors that normally stimulate CK2 activity. In contrast, a peptide corresponding to the amino-terminal 26 amino acids of Rev, including the phosphoacceptor site, is readily phosphorylated by the catalytic subunit of CK2 even in the absence of the beta-subunit. These data, in conjunction with the observation that two functionally inactive derivatives of Rev with mutations in its helix-loop-helix motif are refractory to phosphorylation, indicate the phosphorylation of Rev by CK2 relies on conformational features of distinct regions that are also required for the transactivator's biological activity.
- Published
- 2000
- Full Text
- View/download PDF
48. Influence of Rex and intronic sequences on expression of spliced mRNAs produced by human T cell leukemia virus type I.
- Author
-
D'Agostino DM, Ciminale V, Zotti L, and Chieco-Bianchi L
- Subjects
- Cell Line, Gene Expression, Human T-lymphotropic virus 1 metabolism, Humans, Immunoblotting, Plasmids genetics, RNA, Viral isolation & purification, Response Elements, Gene Products, rex genetics, Human T-lymphotropic virus 1 genetics, Introns genetics, RNA Splicing, RNA, Messenger metabolism, RNA, Viral metabolism
- Abstract
Expression of the incompletely spliced HTLV-I mRNAs relies on the viral posttranscriptional activator Rex, whose interaction with the Rex-responsive element (RXRE) overcomes effects of cis-acting repressive sequences (CRSs). Studies based on heterologous reporter plasmids identified an intronic CRS in the 5' LTR and a CRS that overlaps with the RXRE. The present study investigated the effects of these elements in the context of spliced viral mRNAs encoding p21Rex (mRNA 1-3), Tax/Rex (mRNA 1-2-3), and Tof (mRNA 1-2-B). All three mRNAs were inefficiently expressed when transcribed in their mature intronless form, with the p21Rex mRNA showing the weakest expression. In contrast, efficient expression of p21Rex was obtained from a plasmid containing the 5' LTR and 3' portion of the genome that encoded a spliceable RNA. The defective expression of the intronless mRNAs reflected the inhibitory activity of the RXRE and the lack of 5' intronic sequences. Insertion of an intronic 5' LTR segment located upstream of the 5' CRS overcame Rex dependence conferred by the RXRE. The activity of this segment was mapped to the major splice donor and sequences overlapping with, but functionally distinct from, a previously described transcriptional enhancer. The three mRNAs responded differently to Rex and to insertion of the constitutive transport element of simian retrovirus type 1. Taken together, these results suggest that expression of the spliced mRNAs is controlled by the relative influence of positive and negative sequences present on the primary transcript as well as the Rex-RXRE interaction.
- Published
- 1999
- Full Text
- View/download PDF
49. Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I).
- Author
-
Ciminale V, Zotti L, D'Agostino DM, Ferro T, Casareto L, Franchini G, Bernardi P, and Chieco-Bianchi L
- Subjects
- Amino Acid Sequence, DNA Mutational Analysis, Fluorescent Antibody Technique, Indirect, Genome, Viral, HeLa Cells, Human T-lymphotropic virus 1 genetics, Humans, Molecular Sequence Data, RNA, Messenger genetics, RNA, Viral genetics, Recombinant Fusion Proteins metabolism, Retroviridae Proteins chemistry, Transfection, Alternative Splicing, Genes, pX, Human T-lymphotropic virus 1 physiology, Mitochondria metabolism, Open Reading Frames, Retroviridae Proteins genetics, Retroviridae Proteins metabolism
- Abstract
The X region of the HTLV-I genome contains four major open reading frames (ORFs), two of which, termed x-I and x-II, are of still undefined biological significance. By indirect immunofluorescence and dual labeling with marker proteins, we demonstrate that p13II, an 87-amino acid protein coded by the x-II ORF, is selectively targeted to mitochondria. Mutational analysis revealed that mitochondrial targeting of p13II is directed by an atypical 10-amino acid signal sequence that is not cleaved upon import and is able to target the Green Fluorescent Protein to mitochondria. Expression of p13II results in specific alterations of mitochondrial morphology and distribution from a typical string-like, dispersed network to round-shaped clusters, suggesting that p13II might interfere with processes relying on an intact mitochondrial architecture. Functional studies of mitochondria with the cationic fluorochrome tetramethylrhodamine revealed that a subpopulation of the cells with p13II-positive mitochondria show a disruption in the mitochondrial inner membrane potential (Apsi), an early event observed in cells committed to apoptosis. Taken together, these results suggest novel virus-cell interactions that might be important in HTLV-I replication and/or pathogenicity.
- Published
- 1999
- Full Text
- View/download PDF
50. Analysis of Tax-expressing cell lines generated from HTLV-I tax-transgenic mice: correlation between c-myc overexpression and neoplastic potential.
- Author
-
Saggioro D, D'agostino DM, and Chieco-Bianchi L
- Subjects
- Animals, Cell Division, Cell Line, Gene Products, tax genetics, Human T-lymphotropic virus 1 genetics, Humans, Mice, Mice, Inbred C57BL, Mice, Transgenic, Proto-Oncogene Proteins c-fos biosynthesis, Proto-Oncogene Proteins c-fos genetics, Proto-Oncogene Proteins c-myc genetics, Gene Expression Regulation, Neoplastic, Gene Products, tax biosynthesis, Human T-lymphotropic virus 1 metabolism, Proto-Oncogene Proteins c-myc biosynthesis
- Abstract
Human T-cell leukemia/lymphotropic virus type I (HTLV-I) infection causes a variety of human diseases, including adult T-cell leukemia/lymphoma. The viral transactivator Tax has been implicated as a key factor in the HTLV-I-induced transformation pathway. To investigate the components of this pathway, we derived fibroblast-like cell lines, designated T6 and T9, from tail biopsies of tax-transgenic C57BL/6 mice that do not develop tumors. Phenotypic characterization of T6 and T9 cells and T6-derived subclones revealed that they differ in their abilities to form foci in vitro and tumors in vivo. The observed differences in the levels of Tax expression did not correlate with their degree of neoplastic potential. However, a control cell line derived from a nontransgenic C57BL/6 mouse did not form foci in vitro or tumors in vivo, indicating that Tax was required for the transformation process. Results of Northern analyses showed that the T9 cells and the highly malignant derivatives of T6 cells expressed elevated levels of c-myc mRNA. These findings suggest that progression of the tax-transgenic cells toward a more malignant phenotype might involve c-myc deregulation., (Copyright 1999 Academic Press.)
- Published
- 1999
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.